Photo of Jennifer Buell from LinkedIn
Mar 7, 2024, 01:57
Jennifer Buell: Tune-in: MiNK Therapeutics to unveil pioneering data on the novel armored FAP-CAR-INKT (MiNK-215) at AACR Meeting, April 8
Jennifer Buell, President and Chief Executive Officer at MiNK Therapeutics, shared a post by MiNK Therapeutics on X, adding the following:
“Tune-in: MiNK Therapeutics to unveil pioneering data on the novel armored FAP-CAR-INKT (MiNK-215) at AACR Meeting, April 8. Designed to tackle colorectal cancer liver metastases.”
Quoting MiNK Therapeutic’s post:
“Stay tuned for MiNK’s upcoming presentation at AACR24. On April 8, MiNK will present preclinical data on MiNK-215, our IL-15 armored FAP-targeting CAR-iNKT cell therapy, demonstrating its unique potential against liver metastases in MSS CRC.
Source: Jennifer Buell/X and MiNK Therapeutics/X